Want to join the conversation?
$ALLE is increasing growth expectations for the full-year 2015 by a point. In the Americas, the company is improving 2015 organic revenue growth by 50 BP. Revenue for EMIEA reflects the inclusion of the SimonsVoss and AXA acquisitions, while Asia-Pacific organic revenues are expected to decline by 13-15%.
$YHOO is reporting today after market close. Nobody cares about this stock.
$WBA is yet to receive US anti-trust clearance for its Rite Aid acquisition. The deadline for the deal expires on January 27.
$BMY plunge 7.2%. No credits to the non-acceleration of approval for lung cancer combination treatment.